Search Results

Search results for “clarametyx“

Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Company News
Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Otitis Media Market Size 2022 – Industry Share, Global Sales, Growth Rate with top companies – Blue Water Vaccines Inc, Ceolia Pharma Co Ltd, Clarametyx Biosciences Inc, Earnano LLC
Otitis Media Market Size 2022 – Industry Share, Global Sales, Growth Rate with top companies – Blue Water Vaccines Inc, Ceolia Pharma Co Ltd, Clarametyx Biosciences Inc, Earnano LLC
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Company News
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Company News
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Company News
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Accelerating the Creation of Lifescience Companies in Ohio
Business, Getting Funding, Rev1 News
Accelerating the Creation of Lifescience Companies in Ohio
By Ryan Helon on
Home
Read More
1 2